PTC
BLFS icon

Private Trust Company’s BioLife Solutions BLFS Stock Holding History

Private Trust Company’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-512
Closed -$13.1K – 2557
2025
Q3 		$13.1K Sell
512
-64
-11% -$1.52K ﹤0.01% 1806
2025
Q2 		$12.4K Sell
576
-7
-1% -$158 ﹤0.01% 1741
2025
Q1 		$13.3K Buy
583
+63
+12% +$1.66K ﹤0.01% 1709
2024
Q4 		$13.5K Buy
520
+68
+15% +$1.69K ﹤0.01% 1643
2024
Q3 		$11.3K Buy
452
+61
+16% +$1.44K ﹤0.01% 1670
2024
Q2 		$8.38K Hold
391
– – ﹤0.01% 1746
2024
Q1 		$7.25K Buy
391
+81
+26% +$1.42K ﹤0.01% 1773
2023
Q4 		$5.04K Hold
310
– – ﹤0.01% 1915
2023
Q3 		$4.28K Hold
310
– – ﹤0.01% 1927
2023
Q2 		$6.85K Buy
310
+45
+17% +$948 ﹤0.01% 1771
2023
Q1 		$5.76K Hold
265
– – ﹤0.01% 1803
2022
Q4 		$5K Buy
265
+50
+23% +$1.03K ﹤0.01% 1777
2022
Q3 		$5K Buy
215
+74
+52% +$1.58K ﹤0.01% 1647
2022
Q2 		$2K Buy
+141
New +$2.07K ﹤0.01% 1936

Other funds holding BLFS

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Private Trust Company's BLFS Position: Q4 2025 in Review

Private Trust Company sold out of BioLife Solutions (BLFS) in Q4 2025, closing a stake of 512 shares — an estimated $13.1K sold.

Private Trust Company first reported a position in BLFS in Q2 2022 and held it in 14 quarters. The position peaked at $13.5K in Q4 2024. 187 funds tracked by Wall St. Rank hold BLFS as of Q4 2025.

  • Private Trust Company reported no remaining BioLife Solutions position as of Q4 2025 after selling out during the quarter.
  • Private Trust Company sold 512 BioLife Solutions shares in Q4 2025, an estimated $13.1K.
  • Private Trust Company first reported a position in BioLife Solutions in Q2 2022 and held it in 14 quarters.
  • Private Trust Company's BioLife Solutions position peaked at $13.5K in Q4 2024.
  • 187 funds tracked by Wall St. Rank held BioLife Solutions as of Q4 2025.

Based on Private Trust Company's 13F filing for Q4 2025, filed 26 Jan 2026.